Pseudoepidemics of tuberculin skin test conversions in the U.S. army after recent deployments

American Journal of Respiratory and Critical Care Medicine

Volumn 177, Issue 11, 2008, Pages 1285-1289

  Mancuso, James D ^a   Tobler, Steven K ^b   Keep, Lisa W ^a  

^a Uniformed Services University of the Health Sciences   (United States)

^b Army Medical Surveillance Activity   (United States)

Author keywords

Deployment medicine; Pseudoepidemic; Tuberculin skin test; Tuberculosis infection

Indexed keywords

TUBERCULIN;

ARMY; ARTICLE; CROSS REACTION; ENVIRONMENTAL EXPOSURE; EPIDEMIC; EVALUATION; FALSE POSITIVE RESULT; HUMAN; INFECTION RISK; INTERVIEW; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MILITARY MEDICINE; PREDICTION; PRIORITY JOURNAL; SCREENING TEST; SOLDIER; TRAVEL; TUBERCULIN TEST; TUBERCULOSIS; UNITED STATES; AFGHANISTAN; BOSNIA AND HERZEGOVINA; CUBA; LABORATORY DIAGNOSIS; RISK FACTOR; YUGOSLAVIA;

AFGHANISTAN; BOSNIA-HERZEGOVINA; CUBA; DISEASE OUTBREAKS; FALSE POSITIVE REACTIONS; HUMANS; MILITARY PERSONNEL; RISK FACTORS; TRAVEL; TUBERCULIN TEST; UNITED STATES; YUGOSLAVIA;

EID: 44449146516     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200802-223OC     Document Type: Article

References (50)

1. Daniel TM, Janicki BW. Mycobacterial antigens: a review of their isolation, chemistry, and immunological properties. Microbiol Rev 1978;42:84-113.
2. American Thoracic Society; Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep 2000;49:1-51.
3. Menzies D. Interpretation of repeated tuberculin tests: boosting, conversion, and reversion. Am J Respir Crit Care Med 1999;159:15-21.
4. Rose DN, Schechter CB, Adler JJ. Interpretation of the tuberculin skin test. J Gen Intern Med 1995;10:635-642.
5. American Thoracic Society; Centers for Disease Control and Prevention. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000;161:1376-1395.
6. Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin Infect Dis 1993;17:968-975.
7. Woods ML II, Mooney B, Sutton D, Eutropius L, Chalmers A, Rose RP. A pseudoepidemic of recent tuberculin test conversions caused by a dosing error. Clin Infect Dis 1996;22:389-390.
8. Cieslak TJ, Irwin RG, Dougherty PA, Miller GM. A pseudoepidemic of tuberculin skin test conversions caused by a particular lot of purified protein derivative of tuberculin test solution. Pediatr Infect Dis J 1995;14:392-393.
9. Grabau JC, Hughes SE, Foster EA, Kearns CH, Klopf L. False-positive tuberculin skin tests in a state prison system. Int J Tuberc Lung Dis 2003;7:93-97.
10. Grabau JC, DiFerdinando GT Jr, Novick LF. False positive tuberculosis skin test results. Public Health Rep 1995;110:703-706.
11. Weinbaum CM, Bodnar UR, Schulte J, Atkinson B, Morgan MT, Caliper TE, Valway S, Onorato I. Pseudo-outbreak of tuberculosis infection due to improper skin-test reading. Clin Infect Dis 1998;26:1235-1236.
12. Grabau JC, Burrows DJ, Kern ML. A pseudo-outbreak of purified protein derivative skin-test conversions caused by inappropriate testing materials. Infect Control Hosp Epidemiol 1997;18:571-574.
13. Graham DR, Dan BB, Bertagnoll P, Dixon RE. Cutaneous inflammation caused by inadvertent intradermal administration of DTP instead of PPD. Am J Public Health 1981;71:1040-1043.
14. Centers for Disease Control and Prevention. Notice to readers: inadvertent intradermal administration of tetanus toxoid-containing vaccines instead of tuberculosis skin tests. MMWR Morb Mortal Wkly Rep 2004;53:662-664.
15. Comstock GW. False tuberculin test results. Chest 1975;68(Suppl 3):465-469.
16. Pouchot J, Grasland A, Collet C, Coste J, Esdaile JM, Vinceneux P. Reliability of tuberculin skin test measurement. Ann Intern Med 1997;126:210-214.
17. Longfield JN, Margileth AM, Golden SM, Lazoritz S, Bohan JS, Cruess DF. Interobserver and method variability in tuberculin skin testing. Pediatr Infect Dis 1984;3:323-326.
18. Blackshear J, Bravo E, Gesink D, Davies SF, Iber C, Johnson JR. False positive skin tests with Parke-Davis Aplisol. Am Rev Respir Dis 1983;127:254.
19. Shands JW Jr, Boeff D, Fauerbach L, Gutekunst RR. Tuberculin testing in a tertiary hospital: product variability. Infect Control Hosp Epidemiol 1994;15:758-760.
20. Rupp ME, Schultz AW Jr, Davis JC. Discordance between tuberculin skin test results with two commercial purified protein derivative preparations. J Infect Dis 1994;169:1174-1175.
21. Gillenwater KA, Sapp SC, Pearce K, Siberry GK. Increase in tuberculin skin test converters among health care workers after a change from Tubersol to Aplisol. Am J Infect Control 2006;34:651-654.
22. Lifson AR, Watters JK, Thompson S, Crane CM, Wise F. Discrepancies in tuberculin skin test results with two commercial products in a population of intravenous drug users. J Infect Dis 1993;168:1048-1051.
23. Sbarbaro JA, Iseman MD. "Koch's lymph" 107 years later: an oldie but not a goldie. Clin Infect Dis 1997;25:664-665.
24. Trump DH. Tuberculosis. In: Kelley PW, editor. Military preventive medicine: mobilization and deployment. Vol. 2. Washington, DC: Borden Institute; 2005. pp. 1138-1146.
25. Cowley RG. Implications of the Vietnam War for tuberculosis in the United States. Arch Environ Health 1970;21:479-480.
26. Dantzker DR, Steinberg HN, Kmiecik JE. Primary drug-resistant tuberculosis in Vietnam veterans 1967 to 1970. Am Rev Respir Dis 1972;106:273-274.
27. Harris JO, Lischner MW. Tuberculosis in active duty military personnel. Mil Med 1973;138:427-429.
28. World Health Organization. Global TB database [Internet] [accessed 8 Jan 2008]. Available from: http://www.who.int/tb/country/global_tb_database/en/ index.html
29. U.S. Army; Office of the Surgeon General. Army latent tuberculosis infection (LTBI) surveillance and control program. Washington, DC: Department of the Army; 2003.
30. Rieder HL. Risk of travel-associated tuberculosis. Clin Infect Dis 2001;33:1393-1396.
31. Camarca MM, Krauss MR. Active tuberculosis among US Army personnel, 1980 to 1996. Mil Med 2001;166:452-456.
32. White MR. Hospitalization rates of tuberculosis in US Navy enlisted personnel: a 15-year perspective. Mil Med 1998;163:71-75.
33. Centers for Disease Control and Prevention. Trends in tuberculosis incidence: United States, 2006. MMWR Morb Mortal Wkly Rep 2007;56:245-250.
34. Kelley P, Stikes H, Miller R. An investigation of the incidence of positive tuberculosis skin tests among personnel at the United States Disciplinary Barracks in 1984. Washington, DC: Walter Reed Army Institute of Research, Department of the Army; 1985.
35. Margileth AM, Longfield JN, Golden SM, Lazoritz S, Bohan JS. Tuberculin skin tests: atypical mycobacterial PPD-Battey skin test conversion following airborne training. Mil Med 1986;151:636-638.
36. Patrick SL, Karwacki J, Corr W, Ferguson R, Calder J. Follow-up: cluster of TB skin test converters, US Disciplinary Barracks, Fort Leavenworth, Kansas. Medical Surveillance Monthly Report 1996;2:8,10.
37. Kortepeter MG, Krauss MR. Tuberculosis infection after humanitarian assistance, Guantanamo Bay, 1995. Mil Med 2001;166:116-120.
38. Emmons EE, Ljaamo SK. Active tuberculosis in a deployed field hospital. Mil Med 1999;164:289-292.
39. Cobelens FG, van Deutekom H, Draayer-Jansen IW, Schepp-Beelen AC, van Gerven PJ, van Kessel RP, Mensen ME. Risk of infection with Mycobacterium tuberculosis in travellers to areas of high tuberculosis endemicity. Lancet 2000;356:461-465.
40. Peace Corps Office of Medical Services. The health of the volunteer - 2006. Washington, DC: Peace Corps; 2006.
41. Edwards LB, Acquaviva FA, Livesay VT. Identification of tuberculous infected: dual tests and density of reaction. Am Rev Respir Dis 1973;108:1334-1339.
42. von Reyn CF, Barber TW, Arbeit RD, Sox CH, O'Connor GT, Brindle RJ, Gilks CF, Hakkarainen K, Ranki A, Bartholomew C, et al. Evidence of previous infection with Mycobacterium avium-Mycobacterium intracellulare complex among healthy subjects: an international study of dominant mycobacterial skin test reactions. J Infect Dis 1993;168:1553-1558.
43. Osman AA, Hakim JG, Luneborg-Nielsen M, Bentzon MW, Magnusson M, Ageel AM, Zakaria E, Saleem A, Bakdash I. Comparative skin testing with PPD tuberculin, Mycobacterium avium and M. scrofulaceum sensitin in schoolchildren in Saudi Arabia. Tuber Lung Dis 1994;75:38-43.
44. Lamar JE II, Malakooti MA. Tuberculosis outbreak investigation of a US Navy amphibious ship crew and the Marine expeditionary unit aboard, 1998. Mil Med 2003;168:523-527.
45. Mazurek GH, Zajdowicz MJ, Hankinson AL, Costigan DJ, Toney SR, Rothel JS, Daniels LJ, Pascual FB, Shang N, Keep LW, et al. Detection of Mycobacterium tuberculosis infection in United States Navy recruits using the tuberculin skin test or whole-blood interferon-gamma release assays. Clin Infect Dis 2007;45:826-836.
46. Comstock GW, Edwards LB, Livesay VT. Tuberculosis morbidity in the US Navy: its distribution and decline. Am Rev Respir Dis 1974;110:572-580.
47. Edwards LB, Acquaviva FA, Livesay VT, Cross FW, Palmer CE. An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am Rev Respir Dis 1969;99(Suppl):1-132.
48. Pai M, O'Brien R. Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions? PLoS Med 2007;4:e208.
49. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005;54:49-55.
50. U.S. Air Force. Surveillance, prevention, and control of diseases and conditions of public health or military significance. Washington, DC: U.S. Air Force; 2005. Air Force Instruction 48-105 [1 March 2005].